These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38851890)

  • 1. Genetic analyses of inflammatory polyneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy identified candidate genes.
    Du Z; Lessard S; Iyyanki T; Chao M; Hammond T; Ofengeim D; Klinger K; de Rinaldis E; Shameer K; Chatelain C
    HGG Adv; 2024 Jul; 5(3):100317. PubMed ID: 38851890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-tissue transcriptome-wide association study reveals novel susceptibility genes for migraine.
    Gui J; Yang X; Tan C; Wang L; Meng L; Han Z; Liu J; Jiang L
    J Headache Pain; 2024 Jun; 25(1):94. PubMed ID: 38840241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy.
    Iijima M; Koike H; Katsuno M; Sobue G
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():52-5. PubMed ID: 21696500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways.
    Adewuyi EO; Mehta D; ; ; Nyholt DR
    Hum Reprod; 2022 Jan; 37(2):366-383. PubMed ID: 35472084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of HLA Alleles and Genotypes in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.
    Ghafouri-Fard S; Akbari MT; Houlden H; Mazdeh M; Nazer N; Rezaei O; Taheri M; Sayad A
    J Mol Neurosci; 2022 Mar; 72(3):574-584. PubMed ID: 34596873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.
    Lee G; Xiang Z; Brannagan TH; Chin RL; Latov N
    J Neurol Sci; 2010 Mar; 290(1-2):115-22. PubMed ID: 19922956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression changes in chronic inflammatory demyelinating polyneuropathy skin biopsies.
    Puttini S; Panaite PA; Mermod N; Renaud S; Steck AJ; Kuntzer T
    J Neuroimmunol; 2014 May; 270(1-2):61-6. PubMed ID: 24657030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy.
    Tan CY; Yahya MA; Goh KJ; Shahrizaila N
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109705
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; van Doorn PA; Bengrine T; van Rijs W; Baas F; Nagelkerke SQ; Kuijpers TW; Fokkink WR; Bunschoten C; Broers MC; Willemsen SP; Jacobs BC; Huizinga R
    Eur J Neurol; 2021 May; 28(5):1677-1683. PubMed ID: 33460483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    McCombe PA; Csurhes PA; Greer JM
    J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.
    Hauw F; Fargeot G; Adams D; Attarian S; Cauquil C; Chanson JB; Créange A; Gendre T; Deiva K; Delmont E; Francou B; Genestet S; Kuntzer T; Latour P; Le Masson G; Magy L; Nardin C; Ochsner F; Sole G; Stojkovic T; Maisonobe T; Tard C; Van den Berghe P; Echaniz-Laguna A
    Eur J Neurol; 2021 Sep; 28(9):2846-2854. PubMed ID: 34060689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
    Jomier F; Bousson V; Viala K; Péréon Y; Magot A; Cauquil C; Bouhour F; Vial C; Bedat-Millet AL; Taithe F; Bresch S; Siri A; Kubis N; Lozeron P
    Eur J Neurol; 2020 Jan; 27(1):181-187. PubMed ID: 31348848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
    Ozdag Acarli AN; Tuzun E; Sanli E; Koral G; Akbayir E; Cakar A; Sirin NG; Soysal A; Aysal F; Durmus H; Parman Y; Yilmaz V
    Clin Exp Immunol; 2024 Jan; 215(1):65-78. PubMed ID: 37638717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Mansour M; Seyah A; Riahi A; Gritli N; Mrissa R
    Transfus Apher Sci; 2013 Dec; 49(3):623-6. PubMed ID: 23968987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.